Rationales that providers and family members cited for the use of antipsychotic medications in nursing home residents with dementia

Journal of the American Geriatrics Society

Volumn 63, Issue 2, 2015, Pages 302-308

  Bonner, Alice F ^a   Field, Terry S ^b   Lemay, Celeste A ^b   Mazor, Kathleen M ^b   Andersen, Daniel A ^c   Compher, Christina J ^d   Tjia, Jennifer ^e   Gurwitz, Jerry H ^b  

^a NORTHEASTERN UNIVERSITY   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c CENTERS FOR MEDICARE AND MEDICAID SERVICES   (United States)

^d Healthcare Management Solutions LLC   (United States)

^e UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

antipsychotic medication; dementia; nursing home

Indexed keywords

NEUROLEPTIC AGENT;

AGED; ANGER; ARTICLE; COGNITION; DEMENTIA; DESCRIPTIVE RESEARCH; EMOTION; FAMILY ATTITUDE; FEMALE; HEALTH PERSONNEL ATTITUDE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NURSING HOME PATIENT; PSYCHIATRIC DIAGNOSIS; PSYCHOSIS; QUALITATIVE RESEARCH; QUALITY OF LIFE; SADNESS; VERBAL HOSTILITY; VERY ELDERLY; DEFENSE MECHANISM; FAMILY; HEALTH CARE FACILITY; HEALTH CARE PERSONNEL; NURSING HOME; OFF LABEL DRUG USE; PSYCHOLOGY;

AGED; AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; DEMENTIA; FAMILY; FEMALE; HEALTH FACILITY SIZE; HEALTH PERSONNEL; HUMANS; MALE; NURSING HOMES; OFF-LABEL USE; RATIONALIZATION;

EID: 84923221303     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/jgs.13230     Document Type: Article

References (16)

1. Maher AR, Maglione M, Bagley S, et al. Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: A systematic review and meta-analysis. JAMA 2011; 306: 1359-1369.
2. Schneider LS, Dagerman KS, Insel P,. Risk of death with atypical antipsychotic drug treatment for dementia: Meta-analysis of randomized placebo-controlled trials. JAMA 2005; 294: 1934-1943.
3. Jeste DV, Blazer D, Casey D, et al. ACNP White Paper: Update on use of antipsychotic drugs in elderly persons with dementia. Neuropsychopharmacology 2008; 33: 957-970.
4. FDA Public Health Advisory. Deaths with Antipsychotics in Elderly Patients with Behavioral Disturbances, 2005 [on-line]. Available at http://www.fda.gov/Drugs/DrugSafety/PublicHealthAdvisories/ucm053171.htm Accessed February 5, 2014.
5. Crystal S, Olfson M, Huang C, et al. Broadened use of atypical antipsychotics: Safety, effectiveness, and policy challenges. Health Aff (Millwood) 2009; 28: 770-781.
6. Huybrechts KF, Schneeweiss S, Gerhard T, et al. Comparative safety of antipsychotic medications in nursing home residents. J Am Geriatr Soc 2012; 60: 420-429.
7. Kamble P, Chen H, Sherer JT, et al. Use of antipsychotics among elderly nursing home residents with dementia in the US: An analysis of National Survey Data. Drugs Aging 2009; 26: 483-492.
8. Centers for Medicare and Medicaid Services. Minimum Data Set (MDS) 3.0, Nursing Home Compare. Baltimore, MD: Centers for Medicare and Medicaid Services, 2011.
9. Bowblis JR, Crystal S, Intrator O, et al. Response to regulatory stringency: The case of antipsychotic medication use in nursing homes. Health Econ 2012; 21: 977-993.
10. Chen Y, Briesacher BA, Field TS, et al. Unexplained variation across US nursing homes in antipsychotic prescribing rates. Arch Intern Med 2010; 170: 89-95.
11. Briesacher BA, Limcangco MR, Simoni-Wastila L, et al. The quality of antipsychotic drug prescribing in nursing homes. Arch Intern Med 2005; 165: 1280-1285.
12. Edelman T,. CMA Report: Examining Inappropriate Use of Antipsychotic Drugs in Nursing Facilities. Washington, DC: Center for Medicare Advocacy, Inc., 2013 [on-line]. Available at http://www.medicareadvocacy.org/cma-report-examining-inappropriate-use-of-antipsychotic-drugs-in-nursing-facilities/ Accessed March 11, 2014.
13. U.S. Department of Health and Human Services, Office of Inspector General. Medicare Atypical Antipsychotic Drug Claims for Elderly Nursing Home Residents (NIH report OEI-07-08-00150). Washington, DC: U.S. Department of Health and Human Services, Office of Inspector General, 2011.
14. Lemay CA, Mazor KM, Field TS, et al. Knowledge of and perceived need for evidence-based education about antipsychotic medications among nursing home leadership and staff. J Am Med Dir Assoc 2013; 14: 895-900.
15. Tjia J, Gurwitz JH, Briesacher BA,. Challenge of changing nursing home prescribing culture. Am J Geriatr Pharmacother 2012; 10: 37-46.
16. Centers for Medicare and Medicaid Services. Dementia Care in Nursing Homes: State Operations Manual (SOM). Baltimore, MD: Centers for Medicare and Medicaid Services, 2013.